Meyers 2004
| Methods | RCT: enrolled: not reported evaluated: 401 | |
| Participants | see Mehta 2003 | |
| Interventions | WBRT (3000 cGy/10 fr and motexafin gadolinium vs. WBRT (3000 cGy/ 10 fr) | |
| Outcomes | 1. neurocognitive function and progression | |
| Notes | Same trial as Mehta | |